Compare Remitly Global Inc (RELY) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Remitly Global Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Remitly Global Inc trades at $23.51 (market cap $4.98B), while Relay Therapeutics Inc. Common Stock trades at $17.84 (market cap $3.82B). The key difference: Remitly Global Inc is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is more actively traded (4,332,079 versus 3,501,150). Which is the better fit depends on your goals — on Pluang, investors hold Remitly Global Inc for 53 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| RELY | RLAY | |
|---|---|---|
Market Cap | $4.98B | $3.82B |
Volume | 3,501,150 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $26.92 | $20.75 |
52-Week Low | $12.20 | $6.03 |
Typical Hold Time | 53 Days | 0 Days |
Enterprise Value | $4.34B | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RELY trades at $22.93, down 1.16% on the day, with a bullish technical signal from moving averages. The company shows strong fundamental momentum, with Q2 2026 revenue growth of 20% to $495 million and three consecutive quarterly EPS beats. Analyst consensus is strongly bullish with a $30.50 price target, supported by expanding profit margins and active customer growth exceeding 10 million.
Outlook remains positive given robust revenue growth and profitability expansion, but risks include competitive pressures in fintech and reliance on continued customer acquisition. The stock offers upside to analyst targets, though volatility may persist amid market shifts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
